<DOC>
	<DOCNO>NCT00005652</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine response rate response duration rituximab patient immune thrombocytopenic purpura . II . Evaluate toxicity associate treatment regimen patient . III . Evaluate alteration antiplatelet antibody treatment regimen patient .</brief_summary>
	<brief_title>Phase II Study Rituximab Patients With Immune Thrombocytopenic Purpura</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients receive rituximab IV day 1 , 8 , 15 , 22 . Patients achieve clinical response last 4 month may receive second course rituximab . Patients follow 5 , 6 , 8 , 12 week , 6 9 month .</detailed_description>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Clinically confirm immune thrombocytopenic purpura ( ITP ) Platelet count le 75,000/mm3 two occasion least 1 week apart within past month Normal increase number megakaryocytes bone marrow examination within past 6 month Failed prior steroid therapy ( i.e. , unable achieve sustain platelet count great 75,000/mm3 ) No drug associate ITP No B cell malignancies No evidence disseminate intravascular coagulation ( DIC ) Prior/Concurrent Therapy Endocrine therapy : Concurrent steroid allow long platelet count le 75,000/mm3 dose change within past 2 week study Other : No concurrent medical therapy immune thrombocytopenia purpura ( ITP ) At least 2 week since prior therapy ITP ( except steroid ) At least 4 week since prior cyclosporine Patient Characteristics Performance status : ECOG 02 Life expectancy : At least 6 month Renal : Creatinine great 2.0 mg/dL Cardiovascular : No congestive heart failure symptomatic coronary insufficiency Other : No clinically significant bleeding ( i.e. , mild mucosal bleed petechia ) No sepsis fever No active infection require therapy No active chronic viral infection HIV negative No concurrent prior malignancy within past 5 year except squamous basal cell carcinoma skin carcinoma situ cervix Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>hematologic disorder</keyword>
	<keyword>immune thrombocytopenic purpura</keyword>
	<keyword>rare disease</keyword>
</DOC>